Roche, chasing Merck, notches another lung cancer win

ZURICH (Reuters) - Roche's bid to keep Merck's cancer blockbuster Keytruda within striking distance got a lift on Tuesday when the Swiss drugmaker said its immunotherapy Tecentriq mixed with chemotherapy boosted lung cancer patients' survival.

from Reuters: Health News https://ift.tt/2L3pvfH
via IFTTT